What Causes Colon Cancer in Women? Risks Explained

Colon cancer in women arises from the same broad mix of genetic susceptibility, diet, and lifestyle habits that drives the disease in men, but several factors hit differently depending on sex. Hormones, tumor location patterns, reproductive history, and even screening behavior all shift the risk picture for women in ways that standard overviews tend to gloss over. The rising incidence in younger adults adds urgency, particularly because early-onset rates in women have been climbing faster than in men in some populations.

The Shared Risk Factors That Still Matter Most

Before getting into what is unique for women, it helps to acknowledge that the biggest drivers of colorectal cancer are not sex-specific. A diet heavy in processed meat, low physical activity, excess body weight, smoking, and heavy alcohol use raise the risk for everyone. A meta-analysis of prospective studies found that the highest intake of red and processed meat was linked to roughly a 22% increase in colorectal cancer risk compared with the lowest intake, with processed meat carrying a particularly strong signal.¹ A study focused specifically on women found that those in the highest quartile of processed meat consumption had about a 52% greater risk, and certain cooking methods pushed the numbers higher still: grilled or barbecued steaks roughly doubled the risk compared with the lowest consumption group.²

Alcohol fits a nuanced pattern. A pooled analysis of eight large cohorts found that increased risk was mostly confined to people drinking two or more standard drinks a day, a level reported by about 4% of women and 13% of men.³ A separate meta-analysis reported that light-to-moderate drinking was actually associated with a slightly lower risk in women compared with non-drinkers, while very heavy drinking raised risk primarily in men.⁴ That does not mean moderate alcohol is protective in a causal sense; selection biases in the non-drinking reference group may explain part of the pattern. The practical message is that heavy drinking raises colorectal cancer risk, and women tend to drink less heavily on average, which accounts for some of the gap between the sexes.

Estrogen and the Hormonal Shield

The most distinctive biological factor in women’s colorectal cancer risk is estrogen. Globally, men develop colorectal cancer at higher rates than women, and a growing body of research points to estrogen acting through a specific receptor in the colon lining as part of the explanation.⁵ That receptor appears to help regulate cell growth and suppress the kind of unchecked proliferation that leads to tumors.

The most compelling human evidence comes from the Women’s Health Initiative trial, where postmenopausal women who took combined hormone replacement therapy had a 44% lower rate of invasive colorectal cancer compared with those on placebo.⁶ A meta-analysis of 18 observational studies found a more modest but consistent picture: current users of hormone replacement therapy had about a 34% reduction in colon cancer risk.⁷ A case-control study using pharmacy records confirmed the association and found it was strongest for combined oral preparations, not estrogen-only pills.⁸

This does not mean hormone replacement therapy should be taken to prevent colon cancer. It carries its own serious risks, including increased chances of blood clots and breast cancer, which is why guidelines limit its use to managing menopausal symptoms at the lowest effective dose for the shortest practical time. But the data help explain a biological reality: when estrogen levels drop after menopause, one layer of protection in the colon weakens, and that transition period coincides with a sharper rise in colorectal cancer incidence in women.

Oral Contraceptives and Reproductive History

If estrogen is protective, you might expect oral contraceptives to lower risk too. The evidence generally supports that idea, though the size of the effect varies by study. A meta-analysis pooling case-control and cohort data found that women who had ever used oral contraceptives had about an 18% lower risk of colorectal cancer overall, and recent use was linked to an even larger reduction.⁹ A more recent systematic review reported a pooled risk ratio of 0.53, suggesting roughly halved risk among users, though this estimate was drawn from a smaller set of studies and may overstate the benefit.¹⁰ An earlier case-control study found an inverse association between ever-use of oral contraceptives and colon cancer, with a longer duration of use strengthening the relationship for colon but not rectal cancer.¹¹

Pregnancy history is trickier. One study reported a 30-50% reduction in colon cancer risk associated with having been pregnant, and found that women who had never been pregnant or given birth faced a 40-60% higher risk.¹² However, a dose-response meta-analysis of prospective studies found little evidence that increasing numbers of live births altered colorectal cancer risk at all.¹³ The disagreement likely reflects how difficult it is to separate pregnancy hormones from other lifestyle factors that cluster with reproductive choices: education, diet, healthcare access, and timing of childbearing all shift together. At this point, the evidence suggests pregnancy’s hormonal exposure might be modestly protective, but this is far from settled.

Where Tumors Form Differs by Sex

Colon cancer is not one uniform disease. Tumors on the right side of the colon tend to behave differently from those on the left, and this distinction matters for women. Studies have consistently found that right-sided colorectal cancers occur more often in women and in older patients, while left-sided tumors are more common in men.¹⁴ Right-sided cancers are harder to detect on routine screening because they grow in the ascending colon, farther from the rectum, and they tend to cause vague symptoms like fatigue and unexplained anemia rather than obvious rectal bleeding.

This anatomical pattern has prognostic consequences. One study found that female sex and right-sided tumor location were both independent predictors of worse five-year disease-free survival after surgery for stage III colon cancer. Women with right-sided colon cancer were nearly 1.8 times more likely to experience a recurrence than men with left-sided disease.¹⁵ The reasons are not fully understood, but right-sided tumors tend to have different molecular signatures, grow larger before causing symptoms, and respond differently to certain chemotherapy regimens.

Obesity, Physical Activity, and Metabolic Health

Excess body weight raises colon cancer risk in both sexes, but the connection in women has been studied in large cohorts with clear results. Women with a body mass index above 29 had roughly a 45% higher risk of colon cancer compared with lean women in one major prospective study, while women who were the most physically active cut their risk nearly in half.¹⁶ Another analysis found that moderate activities like brisk walking were enough to reduce the risk of large precancerous polyps in the lower colon, and that the highest body mass carried more than double the risk of those polyps.¹⁷

Type 2 diabetes adds another metabolic layer. It has been identified as an independent risk factor for colorectal cancer, driven in part by chronically elevated insulin levels and inflammation from excess fat tissue.¹⁸ Interestingly, the association appears somewhat weaker in women than in men. In two large U.S. cohorts, type 2 diabetes was linked to a modest, borderline-significant 17% increase in colorectal cancer risk among women, compared with a stronger association in men.¹⁹ Estrogen may again be doing some of the protective work here, blunting the cancer-promoting effects of insulin resistance.

Genetic Syndromes and Family History

About 5-10% of colorectal cancers are driven by inherited gene mutations. Lynch syndrome is the most common hereditary form, and here too the risk differs by sex. Men with Lynch syndrome face a cumulative colorectal cancer risk of about 66% by age 70, while women face a lower but still dramatic risk of roughly 43%.²⁰ Women with Lynch syndrome also carry a high risk of endometrial cancer, and when colorectal and endometrial risks are combined, the cumulative cancer risk for women reaches about 73%. That combined burden means Lynch syndrome in women requires surveillance of both the colon and the uterus, starting much earlier than standard screening age.

Beyond Lynch syndrome, a first-degree relative with colorectal cancer roughly doubles your risk regardless of sex. Women sometimes assume colon cancer is primarily a “men’s disease,” and that misconception can lead to delays in genetic counseling or in following up on family history. If a parent or sibling was diagnosed, particularly before age 50, the recommended screening timeline shifts earlier.

Endometriosis and Chronic Inflammation

A less well-known risk factor unique to women is endometriosis, a condition in which tissue resembling the uterine lining grows outside the uterus, sometimes involving the bowel. Colorectal cancer is the second most common site of cancer arising from endometrial tissue outside the reproductive organs.²¹ The risk appears especially elevated in women with adenomyosis combined with endometriosis at other sites. One population-based study found that this combination was associated with more than a thirteen-fold increase in subsequent colorectal cancer risk, though the confidence interval was wide, reflecting the rarity of both conditions together.²²

Chronic inflammation is a shared thread. Inflammatory bowel diseases like ulcerative colitis and Crohn’s disease are well-established risk factors for colorectal cancer in both sexes. Endometriosis adds a woman-specific inflammatory pathway, particularly when it directly involves the colon or rectum. The research on this link is still maturing, but women with deep-infiltrating bowel endometriosis should discuss their colorectal screening timeline with their doctor.

The Gut Microbiome

The trillions of bacteria living in your colon are not passive bystanders. Several bacterial species have been linked to colorectal cancer development, including certain strains of Fusobacterium, Bacteroides fragilis, and Escherichia coli, which can damage DNA directly or promote chronic inflammation in the gut lining.²³ The microbiome also shapes how the immune system responds to early tumor cells.²⁴

Western-style diets high in processed food and low in fiber appear to promote the kinds of microbiome shifts associated with colorectal cancer.²⁵ Whether the microbiome differs between men and women in ways that specifically alter colon cancer risk is an area of active research without definitive answers yet. But diet is modifiable. Calcium and fiber are worth calling out: women consuming more than 1,000 milligrams of calcium per day showed a 46% decrease in colon cancer risk in one European study, and the benefit was amplified when fiber intake was also high.²⁶ A large cohort study of Chinese women found a similar protective trend for calcium, even at lower overall intake levels than are typical in Western diets.²⁷

Environmental and Occupational Exposures

An emerging area of concern is occupational exposure to endocrine-disrupting chemicals. A study analyzing four Canadian cohorts found that workers exposed to anti-estrogenic chemicals had about a 31% higher risk of colorectal cancer. Exposure to arsenic and polychlorinated biphenyls (PCBs) carried even steeper increases.²⁸ The anti-estrogenic category is particularly relevant for women, because these chemicals may interfere with the same estrogen-receptor pathway that normally helps protect the colon. This research is still early, but it adds weight to the idea that environmental factors can mimic or counteract the hormonal influences that shape women’s cancer risk.

Why Younger Women Are Getting Diagnosed More Often

One of the most alarming trends in colorectal cancer is the rise in early-onset cases, defined as diagnoses before age 50. A German study found that early-onset colorectal cancer incidence was climbing by about 1.3% per year in women, slightly faster than the 1.2% annual increase in men.²⁹ In the United States, the acceleration has been even steeper: after growing by about 1.3% annually from 2001 to 2012, the rate of early-onset colorectal cancer jumped to 3% per year from 2012 to 2017.³⁰

Nobody has a single explanation for this. Obesity rates, shifts in dietary patterns, antibiotic overuse affecting the microbiome, and sedentary lifestyles all plausibly contribute. What makes this relevant for women specifically is that younger women are less likely to have the postmenopausal drop in estrogen, which means the traditional hormonal protection should still be in play. Yet rates are climbing anyway. This suggests that environmental and lifestyle changes may be overwhelming whatever hormonal advantage premenopausal women have.

Screening Barriers Women Face

Knowing the risks is only useful if you get screened. The U.S. Preventive Services Task Force recommends colorectal cancer screening starting at age 45 for average-risk adults, and stool-based tests offer a noninvasive, at-home option for people who are reluctant to undergo colonoscopy.³¹ But women and men face different psychological hurdles. In one mixed-methods study, women were significantly more likely than men to cite fear (14% versus 4%) and the bowel prep (12% versus 1%) as reasons for avoiding colonoscopy.³² Among non-adherent women in Puerto Rico, the single biggest barrier was simply not having a doctor recommend it, reported by half the participants.³³

These patterns point to a practical gap. Women interact with the healthcare system more frequently than men through gynecological visits, prenatal care, and mammography reminders, yet colorectal screening often falls through the cracks because it is not embedded in those existing touchpoints. If a provider does not bring it up, many women assume they are not yet at the age or risk level that warrants it.

Racial and Socioeconomic Disparities

Colorectal cancer risk and outcomes are not evenly distributed. Black Americans have the highest incidence and mortality from colorectal cancer in the United States, driven by a mix of structural factors including lower access to screening, poorer diet quality linked to food insecurity, and less access to high-quality treatment.³⁴ Among younger adults with metastatic disease, Black patients had a three-year survival rate of 41%, compared with 47% for White patients and 58% for Asian patients.³⁵ Neighborhood-level poverty was itself a strong predictor: patients in the poorest neighborhoods had about 50% higher mortality than those in the wealthiest areas, independent of race.³⁶

For women, these disparities compound with the sex-specific barriers already described. A woman of color in a low-income neighborhood may face the combined weight of reduced access to screening, lower likelihood of a provider recommendation, less access to healthful food, and a higher burden of metabolic risk factors. Addressing colorectal cancer in women means addressing these layered structural disadvantages, not just telling people to eat more fiber and exercise.